CapWealth Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

CapWealth Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,000	Closed	-$11K	–	287
2016 Q3	$11K	Hold	2,000	–	–	﹤0.01%	212
2016 Q2	$8K	Hold	2,000	–	–	﹤0.01%	220
2016 Q1	$6K	Hold	2,000	–	–	﹤0.01%	274
2015 Q4	$11K	Hold	2,000	–	–	﹤0.01%	193
2015 Q3	$11K	Hold	2,000	–	–	﹤0.01%	193
2015 Q2	$17K	Hold	2,000	–	–	﹤0.01%	179
2015 Q1	$9K	Buy	+2,000	New	+$6.5K	﹤0.01%	224
2014 Q4	–	Sell	-2,000	Closed	-$6K	–	313
2014 Q3	$6K	Hold	2,000	–	–	﹤0.01%	282
2014 Q2	$8K	Hold	2,000	–	–	﹤0.01%	262
2014 Q1	$11K	Sell	2,000 -28	-1%	-$157	﹤0.01%	245
2013 Q4	$11K	Hold	2,028	–	–	﹤0.01%	256
2013 Q3	$9K	Hold	2,028	–	–	﹤0.01%	317
2013 Q2	$9K	Buy	+2,028	New	+$10.2K	﹤0.01%	302

Other funds holding SGYP

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return